ClinicalTrials.Veeva

Menu
S

Sutter Health | Center of Excellence in Diabetes and Endocrinology

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tirzepatide
Ertugliflozin
PF-04971729
somatrogon
BMF-219
MK-8835-059
Genotropin
LUM-201
MK-8835
LY3298176

Parent organization

This site is a part of Sutter Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 9 total trials
Locations recently updated

A Study of Pitolisant in Patients with Prader-Willi Syndrome

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, global clinical study to assess the efficacy and safety of pitolisant i...

Enrolling
Prader-Willi Syndrome
Other: Placebo tablet
Drug: Pitolisant tablet

The goal of the study is to assess how tirzepatide impacts bodyweight and cardiovascular risk factors when used in conjunction with healthy nutrition...

Enrolling
Weight Gain
Obesity
Drug: Tirzepatide
Drug: Placebo

The purpose of this study is to learn more about the safety and efficacy of tirzepatide compared to placebo in children or teenagers with type 2 diab...

Active, not recruiting
Type2 Diabetes
Glucose Metabolism Disorders
Drug: Placebo
Drug: Tirzepatide Dose 2

This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. Th...

Active, not recruiting
Type 2 Diabetes Mellitus
Biological: Insulin
Drug: Placebo to ertugliflozin 5 mg

Phase 2 Trial of BMF-219 in Participants with Type 1 Diabetes Mellitus.

Active, not recruiting
Type 1 Diabetes Mellitus
Drug: BMF-219

Trial sponsors

Lilly logo
Ascendis Pharma logo
B
H
L
Merck Sharp & Dohme (MSD) logo
Pfizer logo
Roche logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems